{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:34:09Z","timestamp":1792632849833,"version":"4.5.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1053\/j.semdp.2019.12.002","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T05:32:22Z","timestamp":1576647142000},"page":"57-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Pathology and genetics of anaplastic large cell lymphoma"],"prefix":"10.1053","volume":"37","author":[{"given":"Vasiliki","family":"Leventaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan S.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5151","key":"10.1053\/j.semdp.2019.12.002_bib0001","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"issue":"25","key":"10.1053\/j.semdp.2019.12.002_bib0002","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2014-07-588434","article-title":"A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders","volume":"124","author":"Velusamy","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.semdp.2019.12.002_bib0003","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.semdp.2019.12.002_bib0004","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2016-03-707141","article-title":"Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma","volume":"128","author":"Boddicker","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.semdp.2019.12.002_bib0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2019.12.002_bib0006","series-title":"WHO classification of haematopoietic and lymphoid tussues","year":"2008"},{"issue":"20","key":"10.1053\/j.semdp.2019.12.002_bib0007","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.002_bib0008","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.14035","article-title":"Childhood, adolescent and young adult non-Hodgkin lymphoma: state of the science","author":"Cairo","year":"2016","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1053\/j.semdp.2019.12.002_bib0009","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/ejh.12360","article-title":"Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease","volume":"93","author":"Eyre","year":"2014","journal-title":"Eur J Haematol"},{"issue":"12","key":"10.1053\/j.semdp.2019.12.002_bib0010","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semdp.2019.12.002_bib0011","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ajcp\/103.1.82","article-title":"Bone marrow involvement in anaplastic large cell lymphoma. immunohistochemical detection of minimal disease and its prognostic significance","volume":"103","author":"Fraga","year":"1995","journal-title":"Am J Clin Pathol."},{"issue":"9","key":"10.1053\/j.semdp.2019.12.002_bib0012","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/sj.leu.2403888","article-title":"Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma","volume":"19","author":"Mussolin","year":"2005","journal-title":"Leukemia"},{"issue":"10","key":"10.1053\/j.semdp.2019.12.002_bib0013","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1002\/pbc.24591","article-title":"Central nervous system involvement in anaplastic large cell lymphoma in childhood: results from a multicentre European and Japanese study","volume":"60","author":"Williams","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1053\/j.semdp.2019.12.002_bib0014","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1182\/blood-2007-07-100958","article-title":"Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study","volume":"111","author":"Le Deley","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.semdp.2019.12.002_bib0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00277-007-0289-3","article-title":"Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature","volume":"86","author":"Grewal","year":"2007","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1053\/j.semdp.2019.12.002_bib0016","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1440-1827.2009.02376.x","article-title":"Anaplastic large cell lymphoma in leukemic phase: extraordinarily high white blood cell count","volume":"59","author":"Nguyen","year":"2009","journal-title":"Pathol Int"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0017","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1309\/WH8PNU9PK4RRV852","article-title":"ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis. Report of three cases and review of the literature","volume":"120","author":"Onciu","year":"2003","journal-title":"Am J Clin Pathol."},{"issue":"25","key":"10.1053\/j.semdp.2019.12.002_bib0018","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"30","key":"10.1053\/j.semdp.2019.12.002_bib0019","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1200\/JCO.2008.20.1764","article-title":"Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French society of pediatric oncology","volume":"27","author":"Brugieres","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1053\/j.semdp.2019.12.002_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1008352726155","article-title":"Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children\u2013a report from the French society of pediatric oncology","volume":"11","author":"Brugieres","year":"2000","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10040099","article-title":"Treatment options for paediatric anaplastic large cell lymphoma (ALCL): current standard and beyond","volume":"10","author":"Prokoph","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0022","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin's disease associated antigen KI-1 in reactive and neoplastic lymphoid tissue: evidence that reed-sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"issue":"35","key":"10.1053\/j.semdp.2019.12.002_bib0023","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1200\/JCO.2011.36.5411","article-title":"Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study","volume":"29","author":"Lamant","year":"2011","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1053\/j.semdp.2019.12.002_bib0024","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/pbc.25187","article-title":"Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology group","volume":"61","author":"Alexander","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1053\/j.semdp.2019.12.002_bib0025","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","article-title":"ALK-positive lymphoma: a single disease with a broad spectrum of morphology","volume":"91","author":"Benharroch","year":"1998","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.semdp.2019.12.002_bib0026","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000478-199309000-00001","article-title":"A small-cell-predominant variant of primary KI-1 (CD30)+ T-cell lymphoma","volume":"17","author":"Kinney","year":"1993","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0027","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2559.1990.tb01143.x","article-title":"Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+\/Ki-1\u00a0+\u00a0with a high content of reactive histiocytes)","volume":"16","author":"Pileri","year":"1990","journal-title":"Histopathology"},{"issue":"2","key":"10.1053\/j.semdp.2019.12.002_bib0028","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.pas.0000179123.66748.c2","article-title":"ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases","volume":"30","author":"Vassallo","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2019.12.002_bib0029","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1182\/blood.V88.10.4005.bloodjournal88104005","article-title":"Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules","volume":"88","author":"Foss","year":"1996","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.semdp.2019.12.002_bib0030","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.5858\/arpa.2014-0295-CC","article-title":"Anaplastic large cell lymphoma: features presenting diagnostic challenges","volume":"138","author":"Pletneva","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1053\/j.semdp.2019.12.002_bib0031","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1182\/blood.V96.2.398.014k46_398_404","article-title":"Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas","volume":"96","author":"Wellmann","year":"2000","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.semdp.2019.12.002_bib0032","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/DAD.0000000000001061","article-title":"A case of ALK+ anaplastic large-cell lymphoma with aberrant myeloperoxidase expression and initial cutaneous presentation","volume":"40","author":"Gru","year":"2018","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1053\/j.semdp.2019.12.002_bib0033","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"10.1053\/j.semdp.2019.12.002_bib0034","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/sj.onc.1201062","article-title":"ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)","volume":"14","author":"Morris","year":"1997","journal-title":"Oncogene"},{"issue":"3","key":"10.1053\/j.semdp.2019.12.002_bib0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/BJ20090387","article-title":"Anaplastic lymphoma kinase: signalling in development and disease","volume":"420","author":"Palmer","year":"2009","journal-title":"Biochem J"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0036","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1128\/MCB.17.4.2312","article-title":"Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis","volume":"17","author":"Bischof","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1053\/j.semdp.2019.12.002_bib0037","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/bi00429a017","article-title":"Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth","volume":"28","author":"Chan","year":"1989","journal-title":"Biochemistry"},{"issue":"10","key":"10.1053\/j.semdp.2019.12.002_bib0038","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3580","article-title":"Mechanistic insight into alk receptor tyrosine kinase in human cancer biology","volume":"13","author":"Hallberg","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"10.1053\/j.semdp.2019.12.002_bib0039","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1182\/blood-2009-02-204735","article-title":"The proteomic signature of NPM\/ALK reveals deregulation of multiple cellular pathways","volume":"114","author":"Lim","year":"2009","journal-title":"Blood"},{"issue":"35","key":"10.1053\/j.semdp.2019.12.002_bib0040","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1038\/sj.onc.1206849","article-title":"Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma","volume":"22","author":"Amin","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1053\/j.semdp.2019.12.002_bib0041","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4049\/jimmunol.168.1.466","article-title":"Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T\/null-cell lymphoma","volume":"168","author":"Zhang","year":"2002","journal-title":"J Immunol"},{"issue":"2","key":"10.1053\/j.semdp.2019.12.002_bib0042","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2353\/ajpath.2009.080982","article-title":"IL-21 contributes to JAK3\/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma","volume":"175","author":"Dien Bard","year":"2009","journal-title":"Am J Pathol"},{"issue":"32","key":"10.1053\/j.semdp.2019.12.002_bib0043","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1038\/sj.onc.1207703","article-title":"Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma","volume":"23","author":"Amin","year":"2004","journal-title":"Oncogene"},{"issue":"5","key":"10.1053\/j.semdp.2019.12.002_bib0044","doi-asserted-by":"crossref","first-page":"e64544","DOI":"10.1371\/journal.pone.0064544","article-title":"Identification of C\/EBPbeta target genes in ALK+ anaplastic large cell lymphoma (ALCL) by gene expression profiling and chromatin immunoprecipitation","volume":"8","author":"Bonzheim","year":"2013","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1053\/j.semdp.2019.12.002_bib0045","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/labinvest.2017.39","article-title":"Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma","volume":"97","author":"Hwang","year":"2017","journal-title":"Lab Investig"},{"issue":"6","key":"10.1053\/j.semdp.2019.12.002_bib0046","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1182\/blood-2013-01-482026","article-title":"Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK-mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphoma","volume":"122","author":"McDonnell","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.semdp.2019.12.002_bib0047","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1182\/blood-2006-11-059451","article-title":"NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK\/cJun signaling in anaplastic large-cell lymphoma","volume":"110","author":"Leventaki","year":"2007","journal-title":"Blood"},{"issue":"17","key":"10.1053\/j.semdp.2019.12.002_bib0048","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1158\/0008-5472.CAN-05-0925","article-title":"JunB induced by constitutive CD30-extracellular signal-regulated kinase 1\/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma","volume":"65","author":"Watanabe","year":"2005","journal-title":"Cancer Res"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0049","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjh.13079","article-title":"The oncogenic JUNB\/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma","volume":"167","author":"Atsaves","year":"2014","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1053\/j.semdp.2019.12.002_bib0050","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1038\/leu.2015.127","article-title":"Constitutive control of AKT1 gene expression by JUNB\/CJUN in ALK+ anaplastic large-cell lymphoma: a novel crosstalk mechanism","volume":"29","author":"Atsaves","year":"2015","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2019.12.002_bib0051","article-title":"An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma","author":"Lollies","year":"2017","journal-title":"Leukemia"},{"issue":"9","key":"10.1053\/j.semdp.2019.12.002_bib0052","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/s41375-018-0045-9","article-title":"The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17\/ILC3 skewing of anaplastic large cell lymphoma","volume":"32","author":"Schleussner","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"10.1053\/j.semdp.2019.12.002_bib0053","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10010021","article-title":"IRF4 mediates the oncogenic effects of STAT3 in anaplastic large cell lymphomas","volume":"10","author":"Bandini","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.semdp.2019.12.002_bib0054","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2741\/s436","article-title":"The role of AP-1 and epigenetics in ALCL","volume":"7","author":"Schiefer","year":"2015","journal-title":"Front Biosci (Schol Ed)"},{"issue":"2","key":"10.1053\/j.semdp.2019.12.002_bib0055","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.celrep.2016.09.018","article-title":"Insights into the pathogenesis of anaplastic large-cell lymphoma through genome-wide dna methylation profiling","volume":"17","author":"Hassler","year":"2016","journal-title":"Cell Rep"},{"issue":"22","key":"10.1053\/j.semdp.2019.12.002_bib0056","doi-asserted-by":"crossref","first-page":"8611","DOI":"10.1158\/0008-5472.CAN-09-2655","article-title":"NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells","volume":"69","author":"Ambrogio","year":"2009","journal-title":"Cancer Res"},{"issue":"29","key":"10.1053\/j.semdp.2019.12.002_bib0057","doi-asserted-by":"crossref","first-page":"11977","DOI":"10.1073\/pnas.1100319108","article-title":"IL-2R common gamma-chain is epigenetically silenced by nucleophosphin-anaplastic lymphoma kinase (NPM-ALK) and acts as a tumor suppressor by targeting NPM-ALK","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1053\/j.semdp.2019.12.002_bib0058","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/nm1659","article-title":"STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression","volume":"13","author":"Zhang","year":"2007","journal-title":"Nat Med"},{"issue":"19","key":"10.1053\/j.semdp.2019.12.002_bib0059","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1073\/pnas.0501959102","article-title":"STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.semdp.2019.12.002_bib0060","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-18-0359","article-title":"The transcriptional regulator SIN3A contributes to the oncogenic potential of STAT3","author":"Gambi","year":"2019","journal-title":"Cancer Res"},{"issue":"5","key":"10.1053\/j.semdp.2019.12.002_bib0061","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2007.06924.x","article-title":"Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas","volume":"140","author":"Salaverria","year":"2008","journal-title":"Br J Haematol"},{"issue":"15","key":"10.1053\/j.semdp.2019.12.002_bib0062","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1182\/blood-2013-04-497933","article-title":"PRDM1\/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma","volume":"122","author":"Boi","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.semdp.2019.12.002_bib0063","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.critrevonc.2012.06.004","article-title":"Anaplastic large cell lymphoma, ALK-negative","volume":"85","author":"Ferreri","year":"2013","journal-title":"Crit Rev Oncol Hematol."},{"issue":"1","key":"10.1053\/j.semdp.2019.12.002_bib0064","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/PAP.0000000000000047","article-title":"Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous","volume":"22","author":"Xing","year":"2015","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2019.12.002_bib0065","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/PAS.0000000000001174","article-title":"An immune suppression-associated EBV-positive anaplastic large cell lymphoma with a BRAF V600E mutation","volume":"43","author":"Gru","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2019.12.002_bib0066","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","article-title":"Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"40","author":"King","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"33","key":"10.1053\/j.semdp.2019.12.002_bib0067","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1200\/JCO.2012.46.7910","article-title":"Anaplastic large-cell lymphoma with aberrant expression of multiple cytokeratins masquerading as metastatic carcinoma of unknown primary","volume":"31","author":"Nguyen","year":"2013","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0068","first-page":"798","article-title":"Cytokeratin positivity in anaplastic large cell lymphoma: a potential diagnostic pitfall in misdiagnosis of metastatic carcinoma","volume":"6","author":"Zhang","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2019.12.002_bib0069","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2014-10-567461","article-title":"The biology and management of systemic anaplastic large cell lymphoma","volume":"126","author":"Hapgood","year":"2015","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.semdp.2019.12.002_bib0070","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood-2018-03-838524","article-title":"Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"132","author":"Luchtel","year":"2018","journal-title":"Blood"},{"issue":"26","key":"10.1053\/j.semdp.2019.12.002_bib0071","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1182\/blood.2019000626","article-title":"Recurrent MSC (E116K) mutations in ALK-negative anaplastic large cell lymphoma","volume":"133","author":"Luchtel","year":"2019","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.semdp.2019.12.002_bib0072","doi-asserted-by":"crossref","first-page":"18525","DOI":"10.18632\/oncotarget.14503","article-title":"The heterogeneous landscape of ALK negative ALCL","volume":"8","author":"Mereu","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0073","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2016-12-755496","article-title":"DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study","volume":"130","author":"Pedersen","year":"2017","journal-title":"Blood"},{"issue":"10168","key":"10.1053\/j.semdp.2019.12.002_bib0074","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.semdp.2019.12.002_bib0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bjh.14402","article-title":"Clinical manifestations and pathogenesis of cutaneous lymphomas: current status and future directions","volume":"176","author":"Rubio-Gonzalez","year":"2017","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.semdp.2019.12.002_bib0076","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10024-004-8087-6","article-title":"Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature","volume":"8","author":"Kumar","year":"2005","journal-title":"Pediatr Dev Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2019.12.002_bib0077","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5858\/2010-0507-RAR.1","article-title":"Anaplastic large cell lymphoma: twenty-five years of discovery","volume":"135","author":"Kinney","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1053\/j.semdp.2019.12.002_bib0078","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch cutaneous lymphoma group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.semdp.2019.12.002_bib0079","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archdermatol.2009.74","article-title":"Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome","volume":"145","author":"Woo","year":"2009","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1053\/j.semdp.2019.12.002_bib0080","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archdermatol.2009.280","article-title":"Applicability and prognostic value of the new TNM classification system in 135 patients with primary cutaneous anaplastic large cell lymphoma","volume":"145","author":"Benner","year":"2009","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1053\/j.semdp.2019.12.002_bib0081","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2133.2003.05248.x","article-title":"Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. clinicopathological study of four cases and review of the literature","volume":"148","author":"Burg","year":"2003","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1053\/j.semdp.2019.12.002_bib0082","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/DAD.0b013e3181d81dc3","article-title":"Pyogenic variant of primary cutaneous anaplastic large-cell lymphoma: a lymphoproliferative disorder with a predilection for the immunocompromized and the young","volume":"32","author":"Papalas","year":"2010","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1053\/j.semdp.2019.12.002_bib0083","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0190-9622(03)02484-8","article-title":"CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma","volume":"49","author":"Liu","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2019.12.002_bib0084","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","author":"Willemze","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.semdp.2019.12.002_bib0085","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/PAS.0b013e3181648d6d","article-title":"Primary cutaneous ALCL with phosphorylated\/activated cytoplasmic ALK and novel phenotype: EMA\/MUC1+, cutaneous lymphocyte antigen negative","volume":"32","author":"Kadin","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2019.12.002_bib0086","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.2012.065664","article-title":"ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study","volume":"98","author":"Oschlies","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"10.1053\/j.semdp.2019.12.002_bib0087","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1365-2559.2000.00799.x","article-title":"Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins","volume":"36","author":"Boulland","year":"2000","journal-title":"Histopathology"},{"issue":"5","key":"10.1053\/j.semdp.2019.12.002_bib0088","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/1523-1747.ep12337633","article-title":"Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype","volume":"109","author":"Kummer","year":"1997","journal-title":"J Investig Dermatol"},{"issue":"3","key":"10.1053\/j.semdp.2019.12.002_bib0089","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/leu.2008.320","article-title":"Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas","volume":"23","author":"Feldman","year":"2009","journal-title":"Leukemia"},{"issue":"8","key":"10.1053\/j.semdp.2019.12.002_bib0090","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1034\/j.1600-0560.2000.027008392.x","article-title":"Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases","volume":"27","author":"Natkunam","year":"2000","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0091","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/ajcp\/105.4.440","article-title":"CD30-positive cutaneous large cell lymphomas. A comparative study of clinicopathologic and molecular features of 16 cases","volume":"105","author":"Macgrogan","year":"1996","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2019.12.002_bib0092","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0093","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies","volume":"24","author":"Wada","year":"2011","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2019.12.002_bib0094","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/jid.2009.314","article-title":"IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases","volume":"130","author":"Pham-Ledard","year":"2010","journal-title":"J Investig Dermatol"},{"issue":"9","key":"10.1053\/j.semdp.2019.12.002_bib0095","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/PAS.0000000000000217","article-title":"Intralymphatic cutaneous anaplastic large cell lymphoma\/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders","volume":"38","author":"Samols","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2019.12.002_bib0096","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semdp.2019.12.002_bib0097","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2016-02-694455","article-title":"No TP63 rearrangements in a selected group of primary cutaneous CD30+ lymphoproliferative disorders with aggressive clinical course","volume":"128","author":"Schrader","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.semdp.2019.12.002_bib0098","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjd.13476","article-title":"Diagnostic and prognostic significance of CDKN2A\/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease","volume":"172","author":"Nicolae-Cristea","year":"2015","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1053\/j.semdp.2019.12.002_bib0099","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/jid.2010.8","article-title":"Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes","volume":"130","author":"Laharanne","year":"2010","journal-title":"J Investig Dermatol"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0100","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood-2002-08-2434","article-title":"Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas","volume":"101","author":"Mao","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.semdp.2019.12.002_bib0101","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/modpathol.3800419","article-title":"JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis","volume":"18","author":"Rassidakis","year":"2005","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2019.12.002_bib0102","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1074\/jbc.M107653200","article-title":"Inhibition of t cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR)","volume":"277","author":"Alonso","year":"2002","journal-title":"J Biol Chem"},{"issue":"39","key":"10.1053\/j.semdp.2019.12.002_bib0103","doi-asserted-by":"crossref","first-page":"36592","DOI":"10.1074\/jbc.M200453200","article-title":"The dual specificity jkap specifically activates the c-Jun N-terminal kinase pathway","volume":"277","author":"Chen","year":"2002","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1053\/j.semdp.2019.12.002_bib0104","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1073\/pnas.231499098","article-title":"Activation of the JNK signaling pathway by a dual-specificity phosphatase, JSP-1","volume":"98","author":"Shen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1053\/j.semdp.2019.12.002_bib0105","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1074\/jbc.M109.060186","article-title":"JNK pathway-associated phosphatase dephosphorylates focal adhesion kinase and suppresses cell migration","volume":"285","author":"Li","year":"2010","journal-title":"J Biol Chem"},{"issue":"42","key":"10.1053\/j.semdp.2019.12.002_bib0106","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1038\/sj.onc.1209578","article-title":"Regulation of STAT3-mediated signaling by LMW-DSP2","volume":"25","author":"Sekine","year":"2006","journal-title":"Oncogene"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0107","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood-2002-02-0475","article-title":"Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma","volume":"101","author":"Kleinhans","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.semdp.2019.12.002_bib0108","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1365-2133.2005.07039.x","article-title":"Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders","volume":"154","author":"Yamaguchi","year":"2006","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1053\/j.semdp.2019.12.002_bib0109","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/jid.2009.270","article-title":"Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators","volume":"130","author":"van Kester","year":"2010","journal-title":"J Investig Dermatol"},{"issue":"3","key":"10.1053\/j.semdp.2019.12.002_bib0110","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/jid.2009.299","article-title":"Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP","volume":"130","author":"Braun","year":"2010","journal-title":"J Investig Dermatol"},{"issue":"5","key":"10.1053\/j.semdp.2019.12.002_bib0111","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/PRS.0000000000003282","article-title":"U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma","volume":"139","author":"Doren","year":"2017","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1053\/j.semdp.2019.12.002_bib0112","doi-asserted-by":"crossref","first-page":"842","DOI":"10.5858\/arpa.2013-0068-RS","article-title":"Breast implant-associated anaplastic large cell lymphoma: review of a distinct clinicopathologic entity","volume":"138","author":"Xu","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1053\/j.semdp.2019.12.002_bib0113","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/PRS.0000000000001037","article-title":"Breast implant-associated anaplastic large cell lymphoma: a systematic review","volume":"135","author":"Gidengil","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"10.1053\/j.semdp.2019.12.002_bib0114","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jamasurg.2017.4026","article-title":"Breast implant-associated anaplastic large cell lymphoma: a systematic review","volume":"152","author":"Leberfinger","year":"2017","journal-title":"JAMA Surg"},{"issue":"9","key":"10.1053\/j.semdp.2019.12.002_bib0115","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.3324\/haematol.2016.146118","article-title":"Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma","volume":"101","author":"Blombery","year":"2016","journal-title":"Haematologica"},{"issue":"2","key":"10.1053\/j.semdp.2019.12.002_bib0116","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/annonc\/mdv575","article-title":"Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes","volume":"27","author":"Laurent","year":"2016","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1053\/j.semdp.2019.12.002_bib0117","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma","volume":"34","author":"Clemens","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.semdp.2019.12.002_bib0118","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","article-title":"Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients","volume":"32","author":"Miranda","year":"2014","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1053\/j.semdp.2019.12.002_bib0119","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/PRS.0000000000002010","article-title":"Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma","volume":"137","author":"Hu","year":"2016","journal-title":"Plast Reconstr Surg"},{"issue":"9","key":"10.1053\/j.semdp.2019.12.002_bib0120","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood.V93.9.3088.409k30_3088_3095","article-title":"A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation","volume":"93","author":"Lamant","year":"1999","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.semdp.2019.12.002_bib0121","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0002-9440(10)64945-0","article-title":"ATIC-ALK: a novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35)","volume":"156","author":"Colleoni","year":"2000","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2019.12.002_bib0122","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1182\/blood.V94.9.3265","article-title":"TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations","volume":"94","author":"Hernandez","year":"1999","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0123","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/gcc.10033","article-title":"Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor","volume":"34","author":"Cools","year":"2002","journal-title":"Genes Chromosom Cancer"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0124","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V98.4.1209","article-title":"Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4\u2013anaplastic lymphoma kinase gene fusion","volume":"98","author":"Meech","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.semdp.2019.12.002_bib0125","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/gcc.10232","article-title":"Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma","volume":"37","author":"Lamant","year":"2003","journal-title":"Genes Chromosom Cancer"},{"issue":"11","key":"10.1053\/j.semdp.2019.12.002_bib0126","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/gcc.22104","article-title":"Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma","volume":"52","author":"Feldman","year":"2013","journal-title":"Genes Chromosom Cancer"},{"issue":"3","key":"10.1053\/j.semdp.2019.12.002_bib0127","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/leu.2016.331","article-title":"Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex","volume":"31","author":"Palacios","year":"2017","journal-title":"Leukemia"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257019301108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257019301108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:20:32Z","timestamp":1760037632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257019301108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0740257019301108"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2019.12.002","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathology and genetics of anaplastic large cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2019.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}